Aptus Pharma Q4 Results
- BSE: 544529
- NSE: -
- ISIN: INE15XJ01010
- Sector: Biotechnology & Drugs
BSE
271.75
5.30 (1.99%)
5.30 (1.99%)Volume6.00 K
Updated: Fri 6 Mar, 2026 | 14:15:00
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Aptus Pharma Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | - | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 12.08 | - | N/A |
| Depreciation/ Amortization | 0.15 | - | N/A |
| Operating Income | 2.72 | - | N/A |
| Net Income | 1.79 | - | N/A |
| Net Income Before Taxes | 2.44 | - | N/A |
| Other Operating Expenses Total | 4.56 | - | N/A |
| Total Revenue | 14.80 | - | N/A |
| Selling/ General/ Admin Expenses Total | 2.03 | - | N/A |
| Diluted Normalized EPS | 2.62 | - | N/A |